We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgical Decompression Reduces Cerebral Edema in Stroke

By HospiMedica International staff writers
Posted on 24 Apr 2012
Surgical decompression following acute ischemic stroke resulted in significant reduction of death or severe disability one year after recovery, according to a new study.

Researchers at the Saint Louis University School of Medicine (MO, USA) searched the Cochrane Stroke Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966-2010), EMBASE (1980-2010) and the Science Citation Index for studies that examined the effects of decompressive surgery in patients with massive acute ischemic stroke complicated with cerebral edema, as compared to medical treatment alone. More...
Main outcome measures were death at the end of follow-up, death or disability defined as over 3 on the modified Rankin Scale (mRS) at the end of follow-up, death or severe disability defined as mRS over 4 at 12 months, and disability defined as mRS 4 or 5 at 12 months.

The results showed that surgical decompression reduced the risk of death at the end of follow-up and the risk of death or disability (mRS > 4) at 12 months. Death or disability defined as mRS over 3 at the end of follow-up was no different between the treatment arms. Among the 134 adults included in three studies, two studies used a time window from stroke onset of 30 hours to decompression, and 96 hours in the third study. All patients were 60 years of age or younger, and all trials were stopped early. The study was published in the first quarter 2012 issue of the Cochrane Database of Systemic Revues.

“While decompression improves survival and the combined outcome of death and severe disability, the effects on functional outcome are not proven and the patient may survive with significant disability,” concluded lead author Salvador Cruz-Flores, MD, and colleagues of the department of neurology and psychiatry. “The implications for quality of life should be considered when considering this intervention.”

Related Links:

Saint Louis University School of Medicine




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.